Mylet Johanna
Insider CIK 1765988 · PSTX Senior Vice President, Finance
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 35,000 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 4,117 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 80,192 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 82,000 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 111,700 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 125,283 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 72,568 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | D To issuer deriv | 2025-01-08 | 2025-01-08 | 65,000 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | U Tender | 2025-01-08 | 2025-01-08 | 254,852 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 111,700 | — | $0 | 111,700 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | F Tax w/h | 2024-03-01 | 2024-03-04 | 18,091 | $4.13 | $74.7K | 246,283 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2024-03-01 | 2024-03-04 | 80,743 | — | $0 | 264,374 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2023-03-01 | 2023-03-02 | 125,283 | — | $0 | 125,283 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | F Tax w/h | 2023-03-01 | 2023-03-02 | 4,323 | $5.35 | $23.1K | 177,631 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2023-03-01 | 2023-03-02 | 92,772 | — | $0 | 181,954 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-01 | 72,568 | — | $0 | 72,568 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award | 2022-03-01 | 2022-03-01 | 50,000 | — | $0 | 84,231 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-12-21 | 2021-12-22 | 3,100 | — | $0 | 3,816 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-12-21 | 2021-12-22 | 2,616 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-12-21 | 2021-12-22 | 3,100 | $1.93 | $6.0K | 34,231 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-12-21 | 2021-12-22 | 2,616 | $1.17 | $3.1K | 31,131 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2021-11-01 | 2021-11-02 | 65,000 | — | $0 | 65,000 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2021-02-04 | 2021-02-05 | 82,000 | — | $0 | 82,000 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-01-15 | 2021-01-19 | 551 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise deriv | 2021-01-15 | 2021-01-19 | 4,177 | — | $0 | 0 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | M Exercise | 2021-01-15 | 2021-01-19 | 4,728 | $0.30 | $1.4K | 26,813 | SEC↗ |
| PSTX Poseida Therapeutics, Inc. | A Award deriv | 2020-07-09 | 2020-07-13 | 35,000 | — | $0 | 35,000 | SEC↗ |